Similarly, in coronary artery disease, serum OPG is correlated with the severity of PAD as defined by an elevated ABI, independently of the presence of diabetes, suggesting OPG as a robust marker of PAD activity (O’Sullivan et al., 2010). This evidence concerns the gene TNFRSF11B and peripheral arterial disease.